|
|
Pignon J-P, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol. 2008;26:3552–9.
LACE：非小细胞肺癌含顺铂联合辅助化疗的汇总分析
Albain K, et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomized controlled trial. Lancet. 2009;374:379–86.
INT0139/RTOG9309研究：IIIAN2非小细胞肺癌含铂方案诱导化放疗随后放疗VS手术
Dillman R, et al. Improved survival in stage III non-small-cell lung cancer: seven-year follow- up of Cancer and Leukemia Group B (CALGB) 8433 trial. J Natl Cancer Inst. 1996;88:1210–5.
CALGB 8433研究：III期非小细胞肺癌化放疗后的生存：7年随访
Auperin A, et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small cell lung cancer. J Clin Oncol. 2010;28:2181–90.
局部晚期非小细胞肺癌同期和序贯化放疗的meta分析
Vokes E, et al. Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non-small-cell lung cancer: Cancer and Leukemia Group B. J Clin Oncol. 2007;25:1698–704.
CALGB 39801研究：局部晚期不可切除III期非小细胞肺癌：化放疗前诱导化疗
Hanna N, et al. Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: The Hoosier Oncology Group and U.S. Oncology. J Clin Oncol. 2008;26:5755–60.
不可手术局部晚期III期非小细胞肺癌：化放疗后多西他赛巩固治疗
Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomized controlled trials. PORT Meta-analysis Trialists Group. Lancet. 1998;352:257–63.
PORT Meta分析：非小细胞肺癌术后辅助放疗
Douillard J-Y, et al.; for the Adjuvant Navelbine International Trialist Association. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the Adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial. Int J Radiat Oncol Biol Phys. 2008;72(3):695–701.
ANITA：I，II，IIIA非小细胞肺癌完全切除术后的辅助化疗
Bradley J, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small cell lung cancer (RTOG 0617): a randomized, two-by-two factorial phase 3 study. Lancet Oncol. 2015;16:187–99.
RTOG 0617研究：不同剂量放疗治疗不可切除Ⅲ期非小细胞肺癌
Antonia SJ, et al. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. N Engl J Med. 2017;377:1919–29.
PACIFIC：Durvalumab巩固治疗接受含铂化疗同步放疗后未进展的III期不可切除NSCLC
Rusch V, et al. Induction chemoradiation and surgical resection for superior sulcus non-small- cell lung carcinomas: long term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Clin Oncol. 2007;25:313–8.
SWOG 9416/Intergroup 0160研究：肺上沟瘤诱导化放疗后手术：长期随访结果
Le Pechoux C, et al. Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial. Lancet Oncol. 2022 Jan;23(1):104-114. doi: 10.1016/S1470-2045(21)00606-9. Epub 2021 Dec 15. Erratum in: Lancet Oncol. 2022 Jul;23(7):e319.
Lung ART：pN2（IIIA）非小细胞肺癌完全切除术后辅助放疗
|
|
